# Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)

> **NCT05414747** · NA · SUSPENDED · sponsor: **BioFirst Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Retinal Detachment

## Interventions

- **DEVICE:** ABV-1701
- **DEVICE:** SF6 Gas

## Key facts

- **NCT ID:** NCT05414747
- **Lead sponsor:** BioFirst Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-04-15
- **Primary completion:** 2024-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** waiting the new batch of investigational product.
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414747, "Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05414747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*